Breast-carcinoma development presumably results from multiple mutational events in tumor-associated genes. Certain results indicate that some tumor-suppressor genes may combine their pathogenetic potential to synergistically promote tumor growth. In an effort to identify such mechanisms in breast tu
Relationship between loss of estrogen and progesterone receptor expression and of 6q and 11q chromosome arms in breast cancer
β Scribed by H. Magdelenat; M. Gerrault-Seureau; B. Dutrillaux
- Publisher
- John Wiley and Sons
- Year
- 1994
- Tongue
- French
- Weight
- 465 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
An extended analysis for loss of heterozygosity (LOH) on eight chromosomes was conducted in a series of 82 Wilms tumors. Observed rates of allele loss were: 9.5% (1p), 5% (4q), 6% (6p), 3% (7p), 9.8% (11q), 28% (11p15), 13.4% (16q), 8.8% (18p), and 13.8% (22q). Known regions of frequent allele loss
Loss of heterozygosity (LOH, allele loss) occurs frequently on the long arm of chromosome 11 in breast cancer. Seventy-one paired tumourlnormal DNA samples from breast cancer patients under 50 years old were studied for allele loss at four microsatellite loci on llq: DlIS29 (11q23.3), NCAM(llq22923)
Genetic changes have been shown to be important in determining the multistep progression of cancer. Allele loss studies and karyotypic analysis of epithelial ovarian tumours have indicated the presence of putative w m u r suppressor genes on chromosomes 6, I I, I 3, 17, I8,22, and X. We have focused
The prognostic value of epidermal growth factor receptor (EGFR) expression and its biological role in estrogen receptorpositive (ER+) and ER-negative (ER-) primary breast cancer is controversial. In this study, distributions of ER, progesterone receptor and EGFR have been established using immunohis